Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Prices and filings as of the close on Nov 3, 2026
| # | Company | Share price | 1D | Market cap | Yield | Payout ratio | FCF payout | Div. growth yrs | Div. 5Y | Sh. yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 3501 | $53.23 | −0.84% | $8.3B | 1.8% | – | – | 0 | 0.00% | 1.8% | |
| 3502 | $27.14 | +10.5% | $8.3B | – | – | – | – | – | 0.00% | |
| 3503 | $36.35 | −1.8% | $8.3B |
| 5.8% |
| – |
| 220% |
| 2 |
| – |
| 5.8% |
| 3504 | $25.23 | +0.40% | $8.3B | – | – | – | – | – | 0.00% |
| 3505 | $76.77 | −2.4% | $8.4B | 2.2% | – | – | 5 | 44.2% | 4.6% |
| 3506 | $145.12 | −1.3% | $8.4B | 2.4% | 52.8% | – | 10 | 4.9% | −2.5% |
| 3507 | $59.53 | −0.07% | $8.4B | – | – | – | – | – | 0.00% |
| 3508 | fcfsFirstCash | $194.51 | +0.41% | $8.4B | 0.86% | 18.1% | – | 10 | 8.2% | 4.1% |
|---|
| 3509 | $102.03 | −1.6% | $8.4B | – | – | – | – | – | 4.8% |
| 3510 | $437.88 | +2.6% | $8.5B | 0.68% | 10.9% | 18.4% | 1 | 8.6% | 3.9% |
| 3511 | $53.62 | −0.74% | $8.5B | – | – | – | – | – | 0.84% |
| 3512 | $12.82 | −2.0% | $8.5B | – | – | – | – | – | 0.00% |
| 3513 | $65.29 | +5.9% | $8.5B | – | – | – | – | – | 0.00% |
| 3514 | $66.25 | +0.87% | $8.5B | 1.9% | 52.0% | 73.7% | – | – | 9.4% |
| 3515 | $38.28 | −0.80% | $8.5B | 4.5% | – | – | 8 | 14.9% | 12.8% |
| 3516 | $35.07 | +2.7% | $8.5B | 0.91% | 38.4% | 43.0% | 0 | 45.0% | 0.91% |
| 3517 | $44.87 | −0.62% | $8.5B | – | – | – | – | – | 4.3% |
| 3518 | $4.27 | +0.95% | $8.6B | – | – | – | – | – | −3.7% |
| 3519 | $135.62 | +0.53% | $8.6B | 3.5% | 110% | – | 3 | 37.4% | 3.5% |
| 3520 | adcAgree Realty | $68.86 | +0.55% | $8.6B | 4.2% | 157% | – | 2 | – | −9.3% |
|---|
| 3521 | $32.57 | +5.2% | $8.6B | – | – | – | – | – | 0.00% |
| 3522 | $81.63 | +6.6% | $8.6B | – | – | – | – | – | 0.00% |
| 3523 | $247.31 | −0.44% | $8.6B | 1.5% | 17.8% | 10.9% | – | – | 4.8% |
| 3524 | $280.23 | −1.2% | $8.6B | 1.7% | – | – | 15 | 21.1% | 7.1% |
| 3525 | $29.60 | +4.0% | $8.6B | 1.2% | – | – | – | – | 1.2% |
| 3526 | $207.41 | −2.1% | $8.7B | – | – | – | – | – | 5.5% |
| 3527 | $36.71 | +1.6% | $8.7B | 4.1% | 85.9% | – | 11 | 6.0% | −9.6% |
| 3528 | $63.84 | −2.4% | $8.7B | 1.7% | 40.3% | 35.5% | 16 | 7.1% | 5.4% |
| 3529 | $36.67 | −2.1% | $8.7B | 2.3% | 18.1% | – | 4 | 109% | 2.3% |
| 3530 | $30.84 | −1.3% | $8.7B | 4.8% | 55.8% | – | 3 | 12.5% | 10.7% |
| 3531 | $52.37 | +0.50% | $8.7B | – | – | – | – | – | 0.00% |
| 3532 | $383.55 | +1.0% | $8.7B | 0.24% | 4.0% | 2.2% | 7 | 13.6% | 3.8% |
| 3533 | $119.36 | −2.7% | $8.7B | 2.2% | 41.3% | 35.3% | 5 | 38.2% | 7.9% |
| 3534 | $68.47 | −3.8% | $8.8B | 3.1% | – | – | 12 | 14.7% | 3.8% |
| 3535 | syreSpyre Therapeutics | $99.27 | +3.9% | $8.8B | – | – | – | – | – | 0.00% |
|---|
| 3536 | $56.50 | +1.5% | $8.8B | 0.35% | – | 24.1% | – | – | 0.35% |
| 3537 | $8.29 | +4.3% | $8.8B | – | – | – | – | – | 0.00% |
| 3538 | $73.11 | −1.1% | $8.8B | 3.3% | 41.2% | 39.3% | – | – | 3.3% |
| 3539 | $140.30 | +8.7% | $8.8B | – | – | – | – | – | 0.00% |
| 3540 | $22.87 | −0.69% | $8.8B | 1.9% | – | 34.8% | 5 | 27.5% | 1.9% |
| 3541 | $54.24 | +1.3% | $8.8B | 4.5% | 107% | 134% | – | – | 4.5% |
| 3542 | $142.72 | −1.9% | $8.8B | 1.6% | – | 14.2% | 11 | 13.6% | 5.4% |
| 3543 | $164.49 | +3.3% | $8.8B | – | – | – | – | – | 0.00% |
| 3544 | $36.85 | 0.00% | $8.8B | 0.98% | 63.1% | 107% | 1 | – | −3.6% |
| 3545 | $38.50 | −8.5% | $8.8B | 2.1% | – | 16.0% | 1 | – | 8.6% |
| 3546 | $81.93 | +1.8% | $8.9B | – | – | – | – | – | 0.48% |
| 3547 | $22.05 | −0.99% | $8.9B | – | – | – | – | – | 5.8% |
| 3548 | $13.21 | −2.4% | $8.9B | 0.12% | 3.2% | 2.2% | 0 | 19.7% | −0.30% |
| 3549 | $236.71 | −0.85% | $8.9B | 0.84% | – | 15.5% | 12 | 8.7% | 10.9% |
| 3550 | $21.84 | −0.73% | $8.9B | – | – | – | – | – | 0.00% |